Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Strategies

New Report from VPGMarketResearch.com "Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence"
 
NEW YORK - July 13, 2014 - PRLog -- The new report, "Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence," was prepared by Venture Planning Group (www.vpgmarketresearch.com) to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain, UK, and US
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies
 and products
- Specific product and business opportunities for instrument and consumable suppliers.

To review this report, please visit http://www.vpgmarketresearch.com/Winning-Strategies-in-Molecular-Diagnostics--Integrating-New-Technology-Planning-with-Business-and-Corporate-Strategies--Technological-Breakthroughs--Emerging-Tests--Market-Forecasts--Competitive-Intelligence.html

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of molecular diagnostic reagent kits and components.

- Five-year test volume and sales forecasts for major applications, including:

- Infectious Diseases        - Forensic Testing
- Cancer          - Paternity Testing/HLA Typing
- Genetic Diseases          - Others

- Five-year test volume and sales projections for over 30 NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment, including:

- Industrial        - Academic
- Government   - Commercial

- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

- PCR     - bDNA
- SDA     - NASBA
- TMA    - SSSR, and others
- LCR

- Worldwide listings of companies, universities and research centers developing new molecular-diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data base was conducted.

Contains 1050 pages and 96 tables

To review this and related reports, please visit http://www.vpgmarketresearch.com/Molecular-Diagnostics (http://www.vpgmarketresearch.com/Winning-Strategies-in-Mo...)

The report is available by country and can be custom-tailored to specific objectives and information needs.

For further details and questions regarding this report, please contact:

Robert Fisher
Robert@vpgcorp.com
212-564-2838

For related reports, please visit

http://www.VPGMarketResearch.com

http://www.LeadingMarketResearch.com

Contact
Venture Planning Group
***@vpgcorp.com
212-564-2838
End
Source: » Follow
Email:***@vpgcorp.com Email Verified
Tags:Molecular Diagnostics
Industry:Business
Location:New York City - New York - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jul 13, 2014
Venture Planning Group News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share